Evidence map›Paper›PMID 35515677›Full record

ArticleRSC advances2020

Pyrazinamide resistance of novel mutations in

Arif Ali, Muhammad Tahir Khan, Abbas Khan, Sajid Ali, Sathishkumar Chinnasamy, Khalid Akhtar, Athar Shafiq, Dong-Qing Wei

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structural and Dynamic Insights into the W68L, L85P, and T87A Mutations ofInternational journal of environmental research and public health · 2022
    Article
  8. Structural and Genomic Insights Into Pyrazinamide Resistance inFrontiers in molecular biosciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Arif AliState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University 800 Dongchuan Road Shanghai, Minhang District Shanghai 200240 China arifali@sjtu.edu.cn sathishimb@gmail.com Abbaskhan@sjtu.edu.cn Atharshafiq@sjtu.edu.cn dqwei@sjtu.edu.cn +86-21-3420-4573.
Muhammad Tahir KhanDepartment of Bioinformatics and Biosciences, Capital University of Science and Technology Pakistan tahirmicrobiologist@gmail.com pi133001@cust.pk.
Abbas KhanState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University 800 Dongchuan Road Shanghai, Minhang District Shanghai 200240 China arifali@sjtu.edu.cn sathishimb@gmail.com Abbaskhan@sjtu.edu.cn Atharshafiq@sjtu.edu.cn dqwei@sjtu.edu.cn +86-21-3420-4573.ORCID https://orcid.org/0000-0001-8349-5181
Sajid AliQuaid-i-Azam University Islamabad, Provincial Tuberculosis Reference Laboratory Hayatabad Medical Complex Peshawar Pakistan sajidjan@live.com.
Sathishkumar ChinnasamyState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University 800 Dongchuan Road Shanghai, Minhang District Shanghai 200240 China arifali@sjtu.edu.cn sathishimb@gmail.com Abbaskhan@sjtu.edu.cn Atharshafiq@sjtu.edu.cn dqwei@sjtu.edu.cn +86-21-3420-4573.
Khalid AkhtarNational University of Science and Technology Pakistan drkhalidakhtar@smme.edu.pk.
Athar ShafiqState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University 800 Dongchuan Road Shanghai, Minhang District Shanghai 200240 China arifali@sjtu.edu.cn sathishimb@gmail.com Abbaskhan@sjtu.edu.cn Atharshafiq@sjtu.edu.cn dqwei@sjtu.edu.cn +86-21-3420-4573.
Dong-Qing WeiState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University 800 Dongchuan Road Shanghai, Minhang District Shanghai 200240 China arifali@sjtu.edu.cn sathishimb@gmail.com Abbaskhan@sjtu.edu.cn Atharshafiq@sjtu.edu.cn dqwei@sjtu.edu.cn +86-21-3420-4573.ORCID https://orcid.org/0000-0003-4200-7502
Shanghai Jiao Tong University · CNCapital University of Science and Technology · PKQuaid-i-Azam University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrazinamide (PZA) is one of the essential anti-mycobacterium drugs, active against non-replicating

Identifiers

PMID35515677
PMCPMC9056903
OpenAlexW3088496535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.